The board meeting for Sunshine Biopharma Inc is scheduled for today, for the purpose of Sunshine Biopharma Inc First Quarter Earnings Results for 2026See details
Sunshine Biopharma Inc has a share price target of US$ 6, revenue growth forecast of 7.7%, and profit growth estimate of 67.1% for FY26, based on top 1 analyst call.